GE HealthCare Technologies (GEHC) reported $5.7 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 7.1%. EPS of $1.44 for the same period compares to $1.45 a year ago.
The reported revenue represents a surprise of +1.87% over the Zacks Consensus Estimate of $5.59 billion. With the consensus EPS estimate being $1.43, the EPS surprise was +1%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how GE HealthCare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Imaging: $2.55 billion compared to the $2.5 billion average estimate based on four analysts. The reported number represents a change of +6.6% year over year.
- Revenues- AVS (Advanced Visualization Solutions): $1.53 billion compared to the $1.51 billion average estimate based on four analysts.
- Revenues- Other: $7 million compared to the $11.75 million average estimate based on four analysts. The reported number represents a change of -46.2% year over year.
- Revenues- PDx (Pharmaceutical Diagnostics): $790 million compared to the $750.55 million average estimate based on four analysts. The reported number represents a change of +22.3% year over year.
- Revenues- PCS (Patient Care Solutions): $825 million versus $840.42 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -0.2% change.
View all Key Company Metrics for GE HealthCare here>>>
Shares of GE HealthCare have returned -9.2% over the past month versus the Zacks S&P 500 composite's +0.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
GE HealthCare Technologies Inc. (GEHC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
